DFB Healthcare Acquisitions, a blank check company backed by life sciences investment firm Deerfield Management, announced terms for its IPO on Friday.

The New York, NY-based company plans to raise $250 million by offering 25 million units at a price of $10. At that price, DFB Healthcare would command a market value of $313 million. Insiders intend to purchase 2.5 million units on the offering.

DFB Healthcare Acquisitions was founded in 2017 and plans to list on the Nasdaq under the symbol DFBH.RC. Goldman Sachs and Deutsche Bank are the joint bookrunners on the deal.

The article Healthcare SPAC DFB Healthcare files and sets terms for $250 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.